Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report

Antiviral resistance and hepatitis B therapy

(2010) Marc G. Ghany et al.   HEPATOLOGY

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone

(2009) Ju Hyun Shim et al.   HEPATOLOGY

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

(2009) Daniel J. Tenney et al.   HEPATOLOGY

Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations

(2009) J Audsley et al.   HIV MEDICINE

Results of up to 2 years of entecavirvslamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B

(2009) T.-T. Chang et al.   JOURNAL OF VIRAL HEPATITIS

Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus

(2009) A. Boyd et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients

(2009) Rebecca Pastor et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Entecavir therapy for lamivudine‐refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks

(2008) Morris Sherman et al.   HEPATOLOGY

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

(2008) Gail V. Matthews et al.   HEPATOLOGY

Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV)

(2008) Hie-Won Hann et al.   Hepatology International

Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations

(2008) Jessica Tan et al.   JOURNAL OF HEPATOLOGY

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

(2008)   LANCET